Author:
Chakrabarti Malabika,Joshi Nishant,Kumari Geeta,Singh Preeti,Shoaib Rumaisha,Munjal Akshay,Kumar Vikash,Behl Ankita,Abid Mohammad,Garg Swati,Gupta Sonal,Singh Shailja
Abstract
AbstractCytoskeletal structures of Apicomplexan parasites are important for parasite replication, motility, invasion to the host cell and survival. Apicortin, an Apicomplexan specific protein appears to be a crucial factor in maintaining stability of the parasite cytoskeletal assemblies. However, the function of apicortin, in terms of interaction with microtubules still remains elusive. Herein, we have attempted to elucidate the function of Plasmodium falciparum apicortin by monitoring its interaction with two main components of parasite microtubular structure, α-tubulin-I and β-tubulin through in silico and in vitro studies. Further, a p25 domain binding generic drug Tamoxifen (TMX), was used to disrupt PfApicortin-tubulin interactions which led to the inhibition in growth and progression of blood stage life cycle of P. falciparum.
Funder
UGC-SRF
Department of Biotechnology, Ministry of Science and Technology, India
National Post Doctoral Fellowship, DST, India
DST-SERB India
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Trampuz, A., Jereb, M., Muzlovic, I. & Prabhu, R. M. Clinical review: Severe malaria. Crit. Care 7, 315 (2003).
2. Mackintosh, C. L., Beeson, J. G. & Marsh, K. Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20, 597–603 (2004).
3. Bloland, P. B. & Organization, W. H. Drug Resistance in Malaria (World Health Organization, Geneva, 2001).
4. Klein, E. Antimalarial drug resistance: A review of the biology and strategies to delay emergence and spread. Int. J. Antimicrob. Agents 41, 311–317 (2013).
5. Kappes, B. & Rohrbach, P. Microtubule inhibitors as a potential treatment for malaria. Future Microbiology 2(4), 409–423 (2007).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献